Robert J. Bitterman - Feb 26, 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
/s/ Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Feb 26, 2024
Transactions value $
$2,275
Form type
4
Date filed
2/27/2024, 04:42 PM
Previous filing
Feb 22, 2024
Next filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $2.28K +2.5K +15.16% $0.91 19K Feb 26, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.